RCM Technologies, Inc. - 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for RCM Technologies, Inc., a provider of information technology, engineering, and specialty health care staffing and solutions. The report covers the thirteen-week period ended April 2, 2011. The Company is classified as a Smaller Reporting Company and is not a shell company. As of May 3, 2011, there were 13,066,581 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2011 (13 Weeks) | Q1 2010 (13 Weeks) |
|---|---|---|
| Revenues | $38,706,000 | $45,329,000 |
| Gross Profit | $11,050,000 (28.5% margin) | $12,345,000 (27.2% margin) |
| Operating Income | $2,057,000 | $2,088,000 |
| Net Income | $1,175,000 | $1,772,000 |
| Diluted EPS | $0.09 | $0.14 |
| Cash from Operations | $1,908,000 | $1,228,000 |
| Cash and Equivalents (End of Period) | $25,945,000 | $12,252,000 |
| Total Assets | $85,241,000 | $83,012,000 |
| Debt | $0 (No borrowings on $15M facility) | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 14.6% ($6.6 million) year-over-year. This was driven by a 23.0% drop in the Information Technology segment and a 13.6% drop in the Engineering segment. The Specialty Health Care segment saw a 6.9% increase.
- Profitability: Despite lower revenue, Gross Margin improved to 28.5% from 27.2% due to favorable fixed-price contracts and a focus on higher-margin services. Operating income remained relatively flat ($2.057M vs $2.088M) due to a 12.4% reduction in Selling, General, and Administrative (SG&A) expenses.
- Tax Impact: Net income decreased significantly due to a shift from a tax benefit in Q1 2010 (driven by a discrete goodwill deduction) to a tax expense of $0.862 million in Q1 2011. The effective tax rate was 42.3%.
- Discontinued Operations: The Company had no activity in discontinued operations in Q1 2011, compared to a $0.655 million loss in Q1 2010. The Intertec staffing business and Oracle business unit were sold or closed in 2010.
Outlook, Risks, and Management Commentary
- Outlook: Management remains cautious regarding the remainder of 2011, citing a slow and tenuous economic recovery. They anticipate cost of services to revenue ratios to remain comparable to Q1 2011, adjusted for seasonality.
- Capital Allocation: The Company repurchased 145,734 shares for $0.655 million during the quarter. Approximately $6.64 million remains available under the share repurchase program.
- Liquidity: The Company maintains a $15 million revolving credit facility with $14.1 million available. No borrowings were outstanding. Cash increased by $1.24 million during the quarter.
- Risks: Key risks include economic sensitivity, competition, and the ability to retain qualified personnel. The Company faces potential contingent consideration payments of up to $1.292 million related to prior acquisitions (NuSoft and PSG), though management does not expect payments in 2011 to exceed $0.144 million.
- Legal: The Company is involved in various legal actions with asserted claims of approximately $6.6 million. A provision of $0.4 million is currently accrued.
Investor Verification Checklist
- Revenue Drivers: Verify the specific reasons for the 23% revenue drop in the Information Technology segment, particularly regarding the "poor execution" by the sales team and the loss of two major Life Sciences clients.
- Contingent Liabilities: Monitor the performance of acquired businesses (NuSoft and PSG) to assess the likelihood of the $1.292 million maximum deferred consideration becoming payable.
- Legal Exposure: Track the status of pending legal proceedings where asserted claims total $6.6 million against the current $0.4 million accrual.
- Segment Mix: Observe if the Engineering segment's revenue volatility (attributed to timing of major client projects) stabilizes in subsequent quarters.
- Debt Covenants: Confirm the Company's ability to extend or replace its $15 million credit facility, which expires in August 2011.